Clinical Trial Update: Serotonin Norepinephrine Reuptake Inhibitors and the Risk of Serious Adverse Events

View source ↗

Summary

This clinical trial update discusses the risk of serious adverse events associated with serotonin-norepinephrine reuptake inhibitors in patients with chronic ki…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Serotonin-Norepinephrine Reuptake Inhibitors

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Chronic Kidney Disease | Status: COMPLETED